Live Breaking News & Updates on Biomarker Mdx

Stay updated with breaking news from Biomarker mdx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Sepsis Diagnostics Markets Report 2021: Rapid Diagnositics and the Genomics Revolution are Merging to Create New Diagnostic Opportunities


5.3.3 Diagnostics Moves Out of the Lab
5.3.4 Biomarkers and Algorithms
5.3.6 Genome Role and Big Data
5.3.7 The Next Five Years
6 Sepsis Diagnostics - Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Study Establishes Cytovale IntelliSep Test for Rapid Diagnosis of Sepsis
6.3 Baebies Awarded $11.6M to Develop Diagnostic Platform to ID Sepsis
6.4 Personalized Medicine in Sepsis
6.5 Point-of-care Device can Diagnose Sepsis in 30 Minutes
6.6 SpeeDx Developing Respiratory Virus Host-Response Test
6.7 Scanogen Developing Blood Infection Test with Sepsis Application
6.8 Inflammatix Moving Into COVID Test Market and Developing New Sepsis Dx
6.9 Immunexpress, Biocartis to Roll Out Sepsis Test ....

United States , Siemens Healthineers , Qiagen Gmbh , Biomarker Mdx , Laura Wood , Profiles Of Key Companies , Academic Research Lab , Clearance For Blood Panel , Testing Lab , Technology Development , Us Medicare Expenditures For Laboratory Testing , Diagnostics Holdings , Software Service , Diagnostics Ltd , Physician Lab , Immunexpress Extend Sepsis Assay Development Partnership , Biodirection Inc , Diagnostics Moves Out Of The Lab , Office Hours Call , Updates For Rapid Diagnostic Technology , Research Funding , Luminex Corp , E St Office Hours Call , Bio Rad Laboratories Inc , Clinical Laboratory Fees Schedule , Thermo Fisher Scientific Inc ,

Worldwide Industry for Sepsis Diagnostics to 2025 - Featuring Abbott Diagnostics, Abionic and Beckman Coulter Among Others


Share this article
Share this article
ResearchAndMarkets.com s offering.
Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID-19 infections. Understand the different drivers of this huge global diagnostic market and where the opportunity lies. ....

Siemens Healthineers , Qiagen Gmbh , Biomarker Mdx , Laura Wood , Profiles Of Key Companies , Academic Research Lab , Clearance For Blood Panel , Table Sepsis Diagnostic Syndromic Poc Panel , Testing Lab , Public National , Technology Development , Us Medicare Expenditures For Laboratory Testing , Diagnostics Holdings , Diagnostics Ltd , Physician Lab , Immunexpress Extend Sepsis Assay Development Partnership , Biodirection Inc , Milliporesigma Flow Cytometry Research Portfolio , Custom Research , Diagnostics Moves Out Of The Lab , Office Hours Call , Syndromic Poc Panel , Updates For Rapid Diagnostic Technology , Research Funding , Luminex Corp , Sepsis Diagnostic Syndromic Poc Panel Growth ,